大多数胰腺癌病人发现癌症时已经到达中晚期胰腺癌，加上化疗对大多数胰腺肿瘤都没有明显效应。此外，胰腺癌转移到其他部位通常发生在胰腺癌初期阶段，只有少于10％的胰腺肿瘤能够通过手术切除，因此临床预后很差。病人非常疼痛，遭受巨大的痛苦。任何治疗在这一阶段都被视为姑息治疗。
复大肿瘤医院医疗团队在复大肿瘤医院院长，国际冷冻治疗中心首席专家牛立志博士的带领下，采用CT引导下经皮冷冻治疗结合碘125粒子种植和免疫治疗，至今已成功治疗了265例胰腺癌患者，其中大部分病人患有III期或IV期的中晚期胰腺癌。有些患者在复大肿瘤医院接受治疗后已存活6年以上。复大肿瘤医院领先世界的治疗胰腺癌技术已经吸引了来自欧洲，美国，东南亚的很多胰腺癌病人前来诊治。
A World-leading Treatment for Pancreatic Cancer
The majority of the patients suffering from pancreatic cancer present in the late stage of their disease and therefore have poor prognosis. Pancreatic Cancer metastasis usually occurs at early stage, any treatment would be regarded as palliative at this stage. In addition, less than 10% of pancreatic tumor can be surgically removed, and most pancreatic tumors are not responding to chemotherapy. Led by Dr Niu Lizhi who is Chief Specialist in International Cryosurgery Centre, medical teams in FUDA Cancer Hospital have so far treated 265 patients with pancreatic cancer, most of whom have stage III or stage IV of pancreatic cancers by using CT-Guided percutaneous cryosurgery in combination of Iodine 125 seed plantation and immunotherapy. Some patients have survived for more than 6 years after being treated in FUDA.